CARGO Therapeutics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CRGX and buy or sell other stocks, ETFs, and their options commission-free!About CRGX
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy.
CEOKevin Tang
CEOKevin Tang
Employees167
Employees167
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2019
Founded2019
Employees167
Employees167
CRGX Key Statistics
Market cap207.85M
Market cap207.85M
Price-Earnings ratio-0.96
Price-Earnings ratio-0.96
Dividend yield—
Dividend yield—
Average volume1.25M
Average volume1.25M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$25.45
52 Week high$25.45
52 Week low$3.00
52 Week low$3.00
Stock Snapshot
With a market cap of 207.85M, CARGO Therapeutics, Inc.(CRGX) trades at $4.47. The stock has a price-to-earnings ratio of -0.96.
CARGO Therapeutics, Inc.(CRGX) stock opened on 2025-12-15 at —. The price climbed to — and dipped to —.
CARGO Therapeutics, Inc.(CRGX) shares are trading with a volume of 0, against a daily average of 1.25M.
During the past year, CARGO Therapeutics, Inc.(CRGX) stock moved between $3.00 at its lowest and $25.45 at its peak.
During the past year, CARGO Therapeutics, Inc.(CRGX) stock moved between $3.00 at its lowest and $25.45 at its peak.
People also own
Based on the portfolios of people who own CRGX. This list is generated using Robinhood data, and it’s not a recommendation.